BioPharma Dive November 21, 2022
Life science companies see the benefits of moving to a unified clinical operating model
The number of clinical trials has increased from 2,119 in 2000 to more than 409,000 (and counting) in 2022. It’s not just the number of trials that has increased; the amount of data has, too.
The average phase III clinical trial generates 3.6 million data points—three times more data than late-stage trials generated a decade ago—and that data is often collected in different formats, making it difficult for sites, sponsors and contract research organizations (CROs) to manage and understand the influx of information.
“Many clinical operations processes are more time-consuming today than they were five to 10 years ago, which is largely due to increased complexity...
Today's Sponsors
Today's Sponsor